Showing results (1131-1140 of 1,878) with videos related to

Sort By:
Pageof 188
Immunotherapy|September 22, 2018
Rapid complete remission of metastatic melanoma after first-line treatment with nivolumab plus tumor-infiltrating lymphocytesLingdi Zhao, Yonghao Yang, Wei Li, et al.
Immunotherapy|September 22, 2018
Immunotherapy beyond progression in advanced renal cell carcinoma: a case report and review of the literatureSara Elena Rebuzzi, Giacomo Bregni, Massimiliano Grassi, et al.
Immunotherapy|October 18, 2018
Harnessing immune checkpoints for cancer therapyDass S Vinay, Byoung S Kwon
Immunotherapy|October 18, 2018
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa studyMelissa Bersanelli, Diana Giannarelli, Paola Castrignanò, et al.
Immunotherapy|May 30, 2019
Long-term survival and differentiation of human thymocytes in human thymus-grafted immunodeficient miceYang Tang, Yong-Guang Yang, Ou Bai, et al.
Immunotherapy|May 16, 2019
Clinical significance of signs of autoimmune colitis in 18F-fluorodeoxyglucose positron emission tomography-computed tomography of 100 stage-IV melanoma patientsNina Lang, Julika Dick, Alla Slynko, et al.
Immunotherapy|June 23, 2021
CT-P13 subcutaneous infliximab in gastroenterology and rheumatologyMai Ahmed, Giulia Bankov, Dan Casey, et al.
Immunotherapy|January 24, 2018
Benralizumab: an anti-IL-5 receptor α monoclonal antibody in the treatment of asthmaMaciej Kupczyk, Piotr Kuna
Immunotherapy|March 23, 2018
Long-term effect of monophosphoryl lipid A adjuvanted specific immunotherapy in patients with grass pollen allergyStefan Zielen, Jennis Gabrielpillai, Eva Herrmann, et al.
Immunotherapy|March 23, 2018
Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 studyAlessio Cortellini, Melissa Bersanelli, Sebastiano Buti, et al.
Pageof 188